Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
出版年份 2014 全文链接
标题
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
作者
关键词
-
出版物
ANNALS OF THE RHEUMATIC DISEASES
Volume 73, Issue 3, Pages 529-535
出版商
BMJ
发表日期
2014-01-09
DOI
10.1136/annrheumdis-2013-204575
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- FRI0245 Prospective follow-up of tocilizumab treatment in 1100 patients with refractory rheumatoid arthritis: tolerance data from the french registry regate (registry –roactemra)
- (2014) J. Morel et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
- (2014) Cécile Gaujoux-Viala et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2014) Jackie L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
- (2014) Takao Koike et al. Modern Rheumatology
- Tofacitinib for Treatment of Rheumatoid Arthritis
- (2013) Chadi Rakieh et al. ADVANCES IN THERAPY
- EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
- (2013) N Duru et al. ANNALS OF THE RHEUMATIC DISEASES
- Proposal for a new nomenclature of disease-modifying antirheumatic drugs: Table 1
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
- (2013) Pavel Horák et al. CLINICAL RHEUMATOLOGY
- Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster
- (2013) Kevin L. Winthrop et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis
- (2013) Y Hishitani et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry
- (2013) S. Godot et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
- (2013) P. Raaschou et al. BMJ-British Medical Journal
- Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study
- (2012) Kevin L. Winthrop et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2012) James B Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register
- (2012) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study
- (2012) Elizabeth V Arkema et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycobacterial diseases and antitumour necrosis factor therapy in USA
- (2012) KL Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
- (2012) Kevin Haynes et al. ARTHRITIS AND RHEUMATISM
- Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: Drug-specific comparisons in the Swedish Biologics Register
- (2012) Julia F. Simard et al. ARTHRITIS AND RHEUMATISM
- Association between anti-TNF-α therapy and all-cause mortality
- (2012) Lisa J. Herrinton et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
- (2012) L. K. Mercer et al. RHEUMATOLOGY
- Risk of Mortality, Fatal Infection, and Fatal Malignancy Related to Use of Anti-Tumor Necrosis Factor-α Biologics by Rheumatoid Arthritis Patients
- (2012) Veena Thyagarajan et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs
- (2012) Bao-Anh Nguyen-Khoa et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis
- (2012) Jeffrey R. Curtis et al. ARTHRITIS CARE & RESEARCH
- The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
- (2011) J. R. Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
- (2011) R. Davies et al. ANNALS OF THE RHEUMATIC DISEASES
- The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study
- (2011) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
- (2011) A. Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
- (2011) T. Koike et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
- (2011) Lotta Ljung et al. ARTHRITIS AND RHEUMATISM
- Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
- (2011) Carlos G. Grijalva et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety
- (2011) Y. KOMANO et al. JOURNAL OF RHEUMATOLOGY
- TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis
- (2011) Michael A. Lane et al. MEDICINE
- Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
- (2011) Wassila Amari et al. RHEUMATOLOGY
- The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. RHEUMATOLOGY
- Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
- (2010) J. D. Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis
- (2010) J. Sokolove et al. ANNALS OF THE RHEUMATIC DISEASES
- Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
- (2010) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
- (2010) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
- (2010) Mark Lunt et al. ARTHRITIS AND RHEUMATISM
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- The incidence of gastrointestinal perforations among rheumatoid arthritis patients
- (2010) Jeffrey R. Curtis et al. ARTHRITIS AND RHEUMATISM
- Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers
- (2010) A. Strangfeld et al. RHEUMATOLOGY
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
- (2010) J. B. Galloway et al. RHEUMATOLOGY
- Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists
- (2010) Loreto Carmona et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
- (2009) J D Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Demyelinating events in rheumatoid arthritis after drug exposures
- (2009) S. Bernatsky et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada
- (2009) Paul Brassard et al. ARTHRITIS AND RHEUMATISM
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry
- (2009) Francesca Bobbio Pallavicini et al. AUTOIMMUNITY REVIEWS
- Herpes Zoster Risk Factors in a National Cohort of Veterans with Rheumatoid Arthritis
- (2009) Jay R. McDonald et al. CLINICAL INFECTIOUS DISEASES
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
- (2009) T. KOIKE et al. JOURNAL OF RHEUMATOLOGY
- Initiation of rheumatoid arthritis treatments and the risk of serious infections
- (2009) Carlos G. Grijalva et al. RHEUMATOLOGY
- European biologicals registers: methodology, selected results and perspectives
- (2008) A Zink et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
- (2008) J Askling et al. ANNALS OF THE RHEUMATIC DISEASES
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search